interleukin-1beta (163-171) has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, ZL; Qian, DH; Wu, TM; Zhang, JP | 1 |
| Boraschi, D; Dewhirst, FE; Lerner, UH; Ljunggren, O | 1 |
2 other study(ies) available for interleukin-1beta (163-171) and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Inhibitory effect of quercetin on tumor necrosis factor and interleukin-1 beta pro-osteoclastic activities.
Topics: Alkaline Phosphatase; Animals; Bone Resorption; Cell Division; Cells, Cultured; Dinoprostone; Interleukin-1; Interleukin-1beta; Mice; Mice, Inbred ICR; Osteoblasts; Peptide Fragments; Quercetin; Tumor Necrosis Factor-alpha | 1996 |
Comparison of human interleukin-1 beta and its 163-171 peptide in bone resorption and the immune response.
Topics: Amino Acid Sequence; Animals; Antibody Formation; Bone and Bones; Bone Resorption; Bradykinin; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Humans; Indomethacin; Interleukin-1; Interleukin-1beta; Kinetics; Mice; Mice, Inbred C3H; Molecular Sequence Data; Organ Culture Techniques; Peptide Fragments; Recombinant Proteins | 1991 |